These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2893286)

  • 21. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.
    Shirai T; Hirose S; Sekigawa I; Okada T; Sato H
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():11-20. PubMed ID: 3497267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease.
    Babcock SK; Appel VB; Schiff M; Palmer E; Kotzin BL
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7552-5. PubMed ID: 2571993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
    Boswell JM; Yui MA; Burt DW; Kelley VE
    J Immunol; 1988 Nov; 141(9):3050-4. PubMed ID: 3262676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
    Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
    Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.
    Vyse TJ; Halterman RK; Rozzo SJ; Izui S; Kotzin BL
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8098-103. PubMed ID: 10393954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor.
    Kontoyiannis D; Kollias G
    Eur J Immunol; 2000 Jul; 30(7):2038-47. PubMed ID: 10940893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Backcross analysis of genes linked to autoantibody production in New Zealand White mice.
    Vyse TJ; Morel L; Tanner FJ; Wakeland EK; Kotzin BL
    J Immunol; 1996 Sep; 157(6):2719-27. PubMed ID: 8805679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic basis of murine lupus.
    Santiago-Raber ML; Laporte C; Reininger L; Izui S
    Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
    Quezada SA; Eckert M; Adeyi OA; Schned AR; Noelle RJ; Burns CM
    Arthritis Rheum; 2003 Sep; 48(9):2541-54. PubMed ID: 13130474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
    Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus.
    Rozzo SJ; Drake CG; Chiang BL; Gershwin ME; Kotzin BL
    J Immunol; 1994 Aug; 153(3):1340-51. PubMed ID: 7913114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D; Seaman WE
    J Immunol; 1987 May; 138(10):3247-53. PubMed ID: 3106478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.